Xeltis
Clinical trials sponsored by Xeltis, explained in plain language.
-
New heart graft tested in humans for the first time
Disease control ENROLLING_BY_INVITATIONThis study tests a new type of bypass graft for people with severe blockages in multiple heart arteries. About 20 people will receive the graft during planned heart surgery. The goal is to see if the graft works safely and stays open for at least 30 days.
Phase: NA • Sponsor: Xeltis • Aim: Disease control
Last updated May 26, 2026 12:06 UTC
-
New dialysis graft aims to help kidney patients avoid risky surgery
Disease control ENROLLING_BY_INVITATIONThis study tests a new artificial blood vessel (graft) for people with end-stage kidney disease who need dialysis but cannot get a standard fistula. The graft is placed in the arm to allow easy access for dialysis. Researchers will check how safe the graft is and how well it work…
Phase: NA • Sponsor: Xeltis • Aim: Disease control
Last updated May 22, 2026 14:03 UTC